Original source: https://www.investing.com/news/stock-market-news/lillys-nextgen-drug-tops-zepbound-on-weight-loss-in-latestage-osteoarthritis-trial-4403032
Lilly’s next-gen drug tops Zepbound on weight loss in late-stage osteoarthritis trial
Tweet on Twitter
Share on Facebook
Google+
Pinterest